Aquestive Therapeutics Inc (AQST)
SG&A Expense Growth
28.11%
Quarterly · Period ending:
AQST SG&A Expense Growth
Latest reported28.11%period ending
Latest reported28.11%period ending
AQST Quarterly SG&A Growth (QoQ) (0.00% → 28.11%)
Latest values, visible window
High-resolution chart · PNG
AQST sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 28.1133% | |
| -66.556% | |
| 115.2262% | |
| 20.0315% | |
| -33.384% | |
| 19.133% | |
| 32.0221% | |
| 6.7806% | |
| 6.2401% | |
| 11.9267% | |
| 29.3162% | |
| 0.3397% | |
| -1.2743% | |
| -36.8862% | |
| -5.193% | |
| -20.068% | |
| 19.7066% | |
| -13.0832% | |
| 23.5139% | |
| -7.6519% | |
| -0.7331% | |
| -15.0879% | |
| 32.0173% | |
| -15.0497% | |
| -4.9203% | |
| -11.2966% | |
| 20.1254% | |
| -15.5854% | |
| -9.2808% | |
| -4.2507% | |
| 51.5026% | |
| -63.3103% | |
| 344.5369% | |
| 0.0529% | |
| 22.7885% | |
| 17.959% | |
| -14.7683% | |
| 0% |